M&A Deal Summary

Altaris Capital Partners Acquires IntriCon

On February 28, 2022, private equity firm Altaris Capital Partners acquired medical products company IntriCon for 241M USD

Acquisition Highlights
  • This is Altaris Capital Partners’ 13th transaction in the Medical Products sector.
  • This is Altaris Capital Partners’ 5th largest (disclosed) transaction.
  • This is Altaris Capital Partners’ 32nd transaction in the United States.
  • This is Altaris Capital Partners’ 4th transaction in Minnesota.

M&A Deal Summary

Date 2022-02-28
Target IntriCon
Sector Medical Products
Buyer(s) Altaris Capital Partners
Deal Type Going Private
Deal Value 241M USD
Advisor(s) Piper Sandler & Co. (Financial)
Blank Rome (Legal)

Target

IntriCon

Arden Hills, Minnesota, United States
website
IntriCon is a manufacturer and distributor of miniature and micro-miniature body-worn devices for the health care industry. IntriCon was founded in 1930 and is based in Arden Hills, Minnesota.

Search 191,421 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Altaris Capital Partners

New York City, New York, United States

website


Category Private Equity Firm
Founded 2003
PE ASSETS 5.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Altaris Capital Partners is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris Capital Partners was formed in 2004 and is based in New York City.


DEAL STATS #
Overall 34 of 34
Sector (Medical Products) 13 of 13
Type (Going Private) 2 of 2
State (Minnesota) 4 of 4
Country (United States) 32 of 32
Year (2022) 1 of 1
Size (of disclosed) 5 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-17 Veranova

Wayne, Pennsylvania, United States

Veranova is a developer and manufacturer of specialist and complex active pharmaceutical ingredients for pharma and biotech companies. Veranova was founded in 1970 and is based in Wayne, Pennsylvania.

Buy £325M